An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
<strong>Background:<br></strong> Whilst timely clinical characterisation of infections caused by novel SARS-CoV-2 variants is necessary for evidence-based policy response, individual-level data on infecting variants are typically only available for a minority of patients and settin...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
eLife Sciences Publications
2022
|
| _version_ | 1797108668608544768 |
|---|---|
| author | Gonçalves, BP Hall, M Jassat, W Balan, V Murthy, S Kartsonaki, C Semple, MG Rojek, A Baruch, J Reyes, LF Dasgupta, A Dunning, J Citarella, BW Pritchard, M Martín-Quiros, A Sili, U Baillie, JK Aryal, D Arabi, Y Rashan, A Angheben, A Caoili, J Carrier, FM Harrison, EM Gómez-Junyent, J Figueiredo-Mello, C Douglas, JJ Mat Nor, MB Chow, YP Wong, XC Bertagnolio, S Thwin, SS Streinu-Cercel, A Salazar, L Rishu, A Rangappa, R Ong, DSY Hashmi, M Carson, G Diaz, J Fowler, R Kraemer, MUG Wils, E-J Horby, P Merson, L Olliaro, PL |
| author2 | ISARIC Clinical Characterisation Group |
| author_facet | ISARIC Clinical Characterisation Group Gonçalves, BP Hall, M Jassat, W Balan, V Murthy, S Kartsonaki, C Semple, MG Rojek, A Baruch, J Reyes, LF Dasgupta, A Dunning, J Citarella, BW Pritchard, M Martín-Quiros, A Sili, U Baillie, JK Aryal, D Arabi, Y Rashan, A Angheben, A Caoili, J Carrier, FM Harrison, EM Gómez-Junyent, J Figueiredo-Mello, C Douglas, JJ Mat Nor, MB Chow, YP Wong, XC Bertagnolio, S Thwin, SS Streinu-Cercel, A Salazar, L Rishu, A Rangappa, R Ong, DSY Hashmi, M Carson, G Diaz, J Fowler, R Kraemer, MUG Wils, E-J Horby, P Merson, L Olliaro, PL |
| author_sort | Gonçalves, BP |
| collection | OXFORD |
| description | <strong>Background:<br></strong>
Whilst timely clinical characterisation of infections caused by novel SARS-CoV-2 variants is necessary for evidence-based policy response, individual-level data on infecting variants are typically only available for a minority of patients and settings.
<br><strong>
Methods:<br></strong>
Here, we propose an innovative approach to study changes in COVID-19 hospital presentation and outcomes after the Omicron variant emergence using publicly available population-level data on variant relative frequency to infer SARS-CoV-2 variants likely responsible for clinical cases. We apply this method to data collected by a large international clinical consortium before and after the emergence of the Omicron variant in different countries.
<br><strong>
Results:<br></strong>
Our analysis, that includes more than 100,000 patients from 28 countries, suggests that in many settings patients hospitalised with Omicron variant infection less often presented with commonly reported symptoms compared to patients infected with pre-Omicron variants. Patients with COVID-19 admitted to hospital after Omicron variant emergence had lower mortality compared to patients admitted during the period when Omicron variant was responsible for only a minority of infections (odds ratio in a mixed-effects logistic regression adjusted for likely confounders, 0.67 [95% confidence interval 0.61–0.75]). Qualitatively similar findings were observed in sensitivity analyses with different assumptions on population-level Omicron variant relative frequencies, and in analyses using available individual-level data on infecting variant for a subset of the study population.
<br><strong>
Conclusions:<br></strong>
Although clinical studies with matching viral genomic information should remain a priority, our approach combining publicly available data on variant frequency and a multi-country clinical characterisation dataset with more than 100,000 records allowed analysis of data from a wide range of settings and novel insights on real-world heterogeneity of COVID-19 presentation and clinical outcome.
<br><strong>
Funding:<br></strong>
Bronner P. Gonçalves, Peter Horby, Gail Carson, Piero L. Olliaro, Valeria Balan, Barbara Wanjiru Citarella, and research costs were supported by the UK Foreign, Commonwealth and Development Office (FCDO) and Wellcome [215091/Z/18/Z, 222410/Z/21/Z, 225288/Z/22/Z]; and Janice Caoili and Madiha Hashmi were supported by the UK FCDO and Wellcome [222048/Z/20/Z]. Peter Horby, Gail Carson, Piero L. Olliaro, Kalynn Kennon and Joaquin Baruch were supported by the Bill & Melinda Gates Foundation [OPP1209135]; Laura Merson was supported by University of Oxford’s COVID-19 Research Response Fund - with thanks to its donors for their philanthropic support. Matthew Hall was supported by a Li Ka Shing Foundation award to Christophe Fraser. Moritz U.G. Kraemer was supported by the Branco Weiss Fellowship, Google.org, the Oxford Martin School, the Rockefeller Foundation, and the European Union Horizon 2020 project MOOD (#874850). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Contributions from Srinivas Murthy, Asgar Rishu, Rob Fowler, James Joshua Douglas, François Martin Carrier were supported by CIHR Coronavirus Rapid Research Funding Opportunity OV2170359 and coordinated out of Sunnybrook Research Institute. Contributions from Evert-Jan Wils and David S.Y. Ong were supported by a grant from foundation Bevordering Onderzoek Franciscus; and Andrea Angheben by the Italian Ministry of Health “Fondi Ricerca corrente–L1P6” to IRCCS Ospedale Sacro Cuore–Don Calabria. The data contributions of J.Kenneth Baillie, Malcolm G. Semple, and Ewen M. Harrison were supported by grants from the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE) (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Liverpool Experimental Cancer Medicine Centre (grant C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (award IS-BRC-1215-20013), and NIHR Clinical Research Network providing infrastructure support. All funders of the ISARIC Clinical Characterisation Group are listed in the appendix. |
| first_indexed | 2024-03-07T07:31:52Z |
| format | Journal article |
| id | oxford-uuid:68c270b9-257b-46c1-8185-1904ce827210 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:31:52Z |
| publishDate | 2022 |
| publisher | eLife Sciences Publications |
| record_format | dspace |
| spelling | oxford-uuid:68c270b9-257b-46c1-8185-1904ce8272102023-01-20T12:49:14ZAn international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:68c270b9-257b-46c1-8185-1904ce827210EnglishSymplectic ElementseLife Sciences Publications2022Gonçalves, BPHall, MJassat, WBalan, VMurthy, SKartsonaki, CSemple, MGRojek, ABaruch, JReyes, LFDasgupta, ADunning, JCitarella, BWPritchard, MMartín-Quiros, ASili, UBaillie, JKAryal, DArabi, YRashan, AAngheben, ACaoili, JCarrier, FMHarrison, EMGómez-Junyent, JFigueiredo-Mello, CDouglas, JJMat Nor, MBChow, YPWong, XCBertagnolio, SThwin, SSStreinu-Cercel, ASalazar, LRishu, ARangappa, ROng, DSYHashmi, MCarson, GDiaz, JFowler, RKraemer, MUGWils, E-JHorby, PMerson, LOlliaro, PLISARIC Clinical Characterisation Group<strong>Background:<br></strong> Whilst timely clinical characterisation of infections caused by novel SARS-CoV-2 variants is necessary for evidence-based policy response, individual-level data on infecting variants are typically only available for a minority of patients and settings. <br><strong> Methods:<br></strong> Here, we propose an innovative approach to study changes in COVID-19 hospital presentation and outcomes after the Omicron variant emergence using publicly available population-level data on variant relative frequency to infer SARS-CoV-2 variants likely responsible for clinical cases. We apply this method to data collected by a large international clinical consortium before and after the emergence of the Omicron variant in different countries. <br><strong> Results:<br></strong> Our analysis, that includes more than 100,000 patients from 28 countries, suggests that in many settings patients hospitalised with Omicron variant infection less often presented with commonly reported symptoms compared to patients infected with pre-Omicron variants. Patients with COVID-19 admitted to hospital after Omicron variant emergence had lower mortality compared to patients admitted during the period when Omicron variant was responsible for only a minority of infections (odds ratio in a mixed-effects logistic regression adjusted for likely confounders, 0.67 [95% confidence interval 0.61–0.75]). Qualitatively similar findings were observed in sensitivity analyses with different assumptions on population-level Omicron variant relative frequencies, and in analyses using available individual-level data on infecting variant for a subset of the study population. <br><strong> Conclusions:<br></strong> Although clinical studies with matching viral genomic information should remain a priority, our approach combining publicly available data on variant frequency and a multi-country clinical characterisation dataset with more than 100,000 records allowed analysis of data from a wide range of settings and novel insights on real-world heterogeneity of COVID-19 presentation and clinical outcome. <br><strong> Funding:<br></strong> Bronner P. Gonçalves, Peter Horby, Gail Carson, Piero L. Olliaro, Valeria Balan, Barbara Wanjiru Citarella, and research costs were supported by the UK Foreign, Commonwealth and Development Office (FCDO) and Wellcome [215091/Z/18/Z, 222410/Z/21/Z, 225288/Z/22/Z]; and Janice Caoili and Madiha Hashmi were supported by the UK FCDO and Wellcome [222048/Z/20/Z]. Peter Horby, Gail Carson, Piero L. Olliaro, Kalynn Kennon and Joaquin Baruch were supported by the Bill & Melinda Gates Foundation [OPP1209135]; Laura Merson was supported by University of Oxford’s COVID-19 Research Response Fund - with thanks to its donors for their philanthropic support. Matthew Hall was supported by a Li Ka Shing Foundation award to Christophe Fraser. Moritz U.G. Kraemer was supported by the Branco Weiss Fellowship, Google.org, the Oxford Martin School, the Rockefeller Foundation, and the European Union Horizon 2020 project MOOD (#874850). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Contributions from Srinivas Murthy, Asgar Rishu, Rob Fowler, James Joshua Douglas, François Martin Carrier were supported by CIHR Coronavirus Rapid Research Funding Opportunity OV2170359 and coordinated out of Sunnybrook Research Institute. Contributions from Evert-Jan Wils and David S.Y. Ong were supported by a grant from foundation Bevordering Onderzoek Franciscus; and Andrea Angheben by the Italian Ministry of Health “Fondi Ricerca corrente–L1P6” to IRCCS Ospedale Sacro Cuore–Don Calabria. The data contributions of J.Kenneth Baillie, Malcolm G. Semple, and Ewen M. Harrison were supported by grants from the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE) (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Liverpool Experimental Cancer Medicine Centre (grant C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (award IS-BRC-1215-20013), and NIHR Clinical Research Network providing infrastructure support. All funders of the ISARIC Clinical Characterisation Group are listed in the appendix. |
| spellingShingle | Gonçalves, BP Hall, M Jassat, W Balan, V Murthy, S Kartsonaki, C Semple, MG Rojek, A Baruch, J Reyes, LF Dasgupta, A Dunning, J Citarella, BW Pritchard, M Martín-Quiros, A Sili, U Baillie, JK Aryal, D Arabi, Y Rashan, A Angheben, A Caoili, J Carrier, FM Harrison, EM Gómez-Junyent, J Figueiredo-Mello, C Douglas, JJ Mat Nor, MB Chow, YP Wong, XC Bertagnolio, S Thwin, SS Streinu-Cercel, A Salazar, L Rishu, A Rangappa, R Ong, DSY Hashmi, M Carson, G Diaz, J Fowler, R Kraemer, MUG Wils, E-J Horby, P Merson, L Olliaro, PL An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients. |
| title | An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients. |
| title_full | An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients. |
| title_fullStr | An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients. |
| title_full_unstemmed | An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients. |
| title_short | An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients. |
| title_sort | international observational study to assess the impact of the omicron variant emergence on the clinical epidemiology of covid 19 in hospitalised patients |
| work_keys_str_mv | AT goncalvesbp aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT hallm aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT jassatw aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT balanv aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT murthys aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT kartsonakic aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT semplemg aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rojeka aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT baruchj aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT reyeslf aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT dasguptaa aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT dunningj aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT citarellabw aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT pritchardm aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT martinquirosa aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT siliu aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT bailliejk aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT aryald aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT arabiy aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rashana aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT anghebena aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT caoilij aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT carrierfm aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT harrisonem aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT gomezjunyentj aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT figueiredomelloc aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT douglasjj aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT matnormb aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT chowyp aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT wongxc aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT bertagnolios aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT thwinss aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT streinucercela aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT salazarl aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rishua aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rangappar aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT ongdsy aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT hashmim aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT carsong aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT diazj aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT fowlerr aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT kraemermug aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT wilsej aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT horbyp aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT mersonl aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT olliaropl aninternationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT goncalvesbp internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT hallm internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT jassatw internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT balanv internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT murthys internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT kartsonakic internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT semplemg internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rojeka internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT baruchj internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT reyeslf internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT dasguptaa internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT dunningj internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT citarellabw internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT pritchardm internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT martinquirosa internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT siliu internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT bailliejk internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT aryald internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT arabiy internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rashana internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT anghebena internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT caoilij internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT carrierfm internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT harrisonem internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT gomezjunyentj internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT figueiredomelloc internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT douglasjj internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT matnormb internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT chowyp internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT wongxc internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT bertagnolios internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT thwinss internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT streinucercela internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT salazarl internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rishua internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT rangappar internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT ongdsy internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT hashmim internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT carsong internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT diazj internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT fowlerr internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT kraemermug internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT wilsej internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT horbyp internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT mersonl internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients AT olliaropl internationalobservationalstudytoassesstheimpactoftheomicronvariantemergenceontheclinicalepidemiologyofcovid19inhospitalisedpatients |